Drugmakers are pushing back on proposed EU GMP requirements that would expand safeguards against product cross-contamination, saying the proposed six-month timeline for implementation is unworkable. The proposal calls for cross-contamination toxicological risk assessments for any new product introduced into a facility.
Drug Industry Daily